Document type:AB Form 13-501F1 (Class 1 and 3B Reporting Issuers - Participation Fee)
Project number:02857013
Filing date:12-14-2018
This is not the latest filing of type "AB Form 13-501F1 (Class 1 and 3B Reporting Issuers - Participation Fee)" for the IssuerShow the latest document View all the latest filings by Algernon Pharmaceuticals Inc.